Sono-Tek to Present at Spartan Capital's 2025 Investor Conference

Sono-Tek Corporation, the leading developer and manufacturer of ultrasonic coating systems, has announced its participation in Spartan Capital Securities' Second Annual Investor Conference on November 3, 2025, at the Marriott Marquis Hotel in New York City. The event, which will showcase more than 60 carefully selected companies across technology, healthcare, consumer, mining, precious metals, and other high-growth sectors, is expected to attract over 500 institutional and high-net-worth investors. Sono-Tek's presentation at this premier event underscores the conference's mission to spotlight innovative companies positioned for long-term growth, with CEO Steve Harshbarger expressing honor at the opportunity to share the company's growth story with a distinguished audience of investors and peers through this unique platform.

The conference represents a significant opportunity for Sono-Tek to connect with both existing and new investors through main-stage presentations, expert panels, curated one-on-one meetings, and extensive networking sessions. Spartan Capital Securities, known for its extensive market knowledge and personalized service, has built its reputation on helping growth companies access the right investors and resources, with founder John D. Lowry emphasizing the conference's role in bringing together high-quality companies and serious investors under one roof. For those interested in attending, registration details are available through the Spartan Capital Investor Conference 2025 Registration page on the B2i Digital platform, providing access to this powerful networking and investment opportunity.

Sono-Tek's participation highlights the company's position as a global leader in ultrasonic coating systems that serve diverse industries including medical devices, semiconductors, microelectronics, alternative energy, and advanced industrial manufacturing. The company has a particularly strong history in medical device coatings for life-saving technologies such as stents, balloons, diagnostic devices, and drug delivery platforms, while simultaneously expanding its expertise in semiconductor applications for next-generation chips, displays, and sensors. As Sono-Tek transitions from R&D tools to high-volume production machines with significantly higher average selling prices, the company's growth strategy focuses on leveraging innovative technologies and global reach to develop microscopic coating technologies that enable better outcomes for customers' products and processes across multiple sectors.